Global Ranitidine Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Ranitidine market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Ranitidine market."
Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger“Ellison syndrome. It could be taken orally or intravenously. 

The global Ranitidine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ranitidine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ranitidine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GSK
    Merck
    Boehringer Ingelheim
    Strides Pharma Science Limited (Strides Shasun)
    Sun Pharma
    Tocris Bioscience (R & D Systems)
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Tablet
    Syrup
    Injection

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies